Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2020-04-24 Legal Proceedings Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Lynparza shows overall survival in prostate cancer
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 7689K' and is dated April 24, 2020. It announces positive Phase III trial results for the drug Lynparza, detailing survival benefits and referencing regulatory submissions ('regulatory reviews ongoing in the EU and other jurisdictions'). The content is a press release format providing specific clinical and commercial updates, which is typical of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is a detailed announcement of clinical trial data and partnership updates, rather than just a brief notice of report publication, it fits best as an Earnings Release (ER) if it were tied to a reporting period, or a general Regulatory Filing (RNS) as it is distributed via the RNS system. Given the nature of the announcement (drug trial results, not quarterly financials), RNS is the most appropriate general regulatory announcement category, as ER usually implies quarterly financial results highlights. However, the content is a substantial announcement of clinical progress, which often accompanies or substitutes for an ER in biotech/pharma. Since it is explicitly distributed via RNS and contains significant corporate/product news, RNS is the safest classification, although ER is plausible if this was released alongside quarterly results. Given the explicit RNS header and the nature of the announcement (drug trial data), I will classify it as RNS, the general regulatory announcement category.
2020-04-24 English
CHANGES TO ARRANGEMENTS FOR ANNUAL GENERAL MEETING
Foreign Filer Report
2020-04-17 English
Changes to arrangements for AGM
AGM Information Classification · 98% confidence The document explicitly discusses 'Changes to arrangements for Annual General Meeting' (AGM) and details how the meeting will proceed under COVID-19 restrictions (closed meeting, proxy voting). This directly relates to the AGM process. Although it is distributed via RNS (Regulatory News Service), the core subject matter is the AGM arrangements, making AGM-R the most specific and appropriate classification over the general RNS fallback. The document is short and serves as an announcement regarding the AGM logistics.
2020-04-17 English
KOSELUGO (SELUMETINIB) APPROVED IN US FOR PAEDIATRIC PATIENTS WITH NEUROFIBROMAT
Foreign Filer Report
2020-04-14 English
TAGRISSO PHASE III ADAURA TRIAL WILL BE UNBLINDED EARLY AFTER OVERWHELMING EFFIC
Foreign Filer Report
2020-04-14 English
Tagrisso adjuvant trial overwhelmingly positive
Regulatory Filings Classification · 98% confidence The document is an official announcement from AstraZeneca regarding the results of a clinical trial (ADAURA). It is labeled as an 'RNS' (Regulatory News Service) filing, which is a standard format for corporate announcements in the UK. Since it reports on clinical trial efficacy rather than financial results, dividends, or governance, and is distributed via a regulatory news service, it falls under the 'Regulatory Filings' category.
2020-04-14 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.